4//SEC Filing
Bhavnagri Veer 4
Accession 0001593968-23-000168
CIK 0001737287other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:10 PM ET
Size
4.5 KB
Accession
0001593968-23-000168
Insider Transaction Report
Form 4
Bhavnagri Veer
General Counsel
Transactions
- Sale
Common Stock
2023-01-17$7.04/sh−3,000$21,120→ 580,677 total
Footnotes (1)
- [F1]1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001808980
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 6:10 PM ET
- Size
- 4.5 KB